How the EU will speed up approval of eventual COVID-19 vaccine, in contrast to what has happened in U.S.

European health regulator launches a “rolling review” of the coronavirus vaccine being developed by Pfizer and BioNTech, as it did for the competing Oxford-AstraZeneca vaccine.